:root{ --bg:#F3F6FB; --surface:#fff; --alt:#F7F9FD; --border:#E4E9F2; --text:#1B2A4A; --muted:#7A8AA8; --green:#4E9A2F; --greenA:#8cc046; --red:#D64545; --navy:#1B2A4A; --blue:#3F6FB0; } *{box-sizing:border-box} body{margin:0;background:var(--bg);color:var(--text);font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif} a{color:var(--blue)} .muted{color:var(--muted)} .err{background:#FBE9E9;color:var(--red);padding:10px;border-radius:8px;font-size:14px} .ok{background:#EBF4DF;color:var(--green);padding:10px;border-radius:8px;font-size:14px} /* Auth */ .auth-body{display:grid;place-items:center;min-height:100vh} .auth-card{background:var(--surface);border:1px solid var(--border);border-radius:16px;padding:30px;width:340px;box-shadow:0 4px 24px rgba(27,42,74,.06)} .auth-card h2{margin:6px 0 18px;font-size:20px} .auth-card label{display:block;font-size:13px;color:var(--muted);margin-bottom:12px} .auth-card input{width:100%;margin-top:5px;padding:10px;border:1px solid var(--border);border-radius:8px;font-size:14px} .brand{display:flex;align-items:center;gap:9px;font-size:18px;font-weight:700} .brand b{color:var(--greenA);font-weight:700} .brand-bar{width:9px;height:22px;background:var(--greenA);border-radius:3px;display:inline-block} /* Buttons */ .btn-primary{background:var(--greenA);color:#173a05;border:0;border-radius:9px;padding:10px 18px;font-weight:700;font-size:14px;cursor:pointer;width:100%} .btn-sm{background:var(--greenA);color:#173a05;border:0;border-radius:8px;padding:8px 14px;font-weight:700;font-size:13px;cursor:pointer;width:auto} .btn-ghost{background:transparent;color:var(--muted);border:1px solid var(--border);border-radius:8px;padding:8px 14px;font-weight:600;font-size:13px;cursor:pointer} .icon-btn{background:transparent;border:0;color:var(--muted);cursor:pointer;font-size:14px;padding:2px 6px} /* Topbar */ .topbar{background:var(--navy);color:#fff;padding:10px 18px;display:flex;align-items:center;gap:12px;flex-wrap:wrap} .topbar .brand b{color:var(--greenA)} .nav{display:flex;gap:4px;flex-wrap:wrap;margin-left:8px} .nav button{background:transparent;color:#B9C4DA;border:1px solid transparent;padding:6px 12px;border-radius:8px;font-size:13px;cursor:pointer;font-weight:600} .nav button.active{background:rgba(140,192,70,.22);color:#fff;border-color:var(--greenA)} .top-right{margin-left:auto;display:flex;gap:8px;align-items:center} .top-right select,.top-right .pill{background:rgba(255,255,255,.12);color:#fff;border:1px solid rgba(255,255,255,.18);border-radius:8px;padding:6px 10px;font-size:12.5px;cursor:pointer} .wrap{max-width:1180px;margin:0 auto;padding:18px 16px 70px} .section{display:none} .section.active{display:block} /* Cards & stats */ .card{background:var(--surface);border:1px solid var(--border);border-radius:14px;padding:16px;box-shadow:0 1px 2px rgba(27,42,74,.04)} .card+.card{margin-top:14px} .card-head{display:flex;align-items:center;justify-content:space-between;margin-bottom:14px;gap:10px} .card-head h3{font-size:14px;font-weight:700;margin:0} .grid2{display:grid;grid-template-columns:1fr 1fr;gap:14px;margin-top:14px} .stats{display:grid;grid-template-columns:repeat(auto-fit,minmax(155px,1fr));gap:12px} .stat{background:var(--surface);border:1px solid var(--border);border-radius:12px;padding:14px 16px} .stat .lab{color:var(--muted);font-size:12px;margin-bottom:6px} .stat .val{font-size:20px;font-weight:700;font-variant-numeric:tabular-nums} .stat .sub{color:var(--muted);font-size:11px;margin-top:4px} .pos{color:var(--green)} .neg{color:var(--red)} /* Tables */ table{width:100%;border-collapse:collapse;font-size:13px} th{color:var(--muted);font-size:11px;text-align:left;padding:0 10px 8px;font-weight:600} td{padding:9px 10px;border-top:1px solid var(--border);vertical-align:middle} .r{text-align:right} .badge{padding:2px 8px;border-radius:20px;font-size:11px;font-weight:600} .badge.win{color:var(--green);background:#EBF4DF} .badge.loss{color:var(--red);background:#FBE9E9} /* Calendar */ .cal{display:grid;grid-template-columns:repeat(7,1fr);gap:4px} .cal .dow{text-align:center;color:var(--muted);font-size:10px;font-weight:600;padding-bottom:4px} .cal .cell{border:1px solid var(--border);border-radius:6px;min-height:50px;padding:4px 5px;display:flex;flex-direction:column;justify-content:space-between} .cal .cell .d{font-size:10px;color:var(--muted)} .cal .cell .p{font-size:11px;font-weight:700} /* Day cards */ .day{display:flex;align-items:center;gap:12px;flex-wrap:wrap} .day .net{font-weight:700} .day .metrics{margin-left:auto;display:flex;gap:22px;font-size:12.5px;color:var(--muted);flex-wrap:wrap} /* Breakdown */ .bd-head,.bd-row{display:grid;grid-template-columns:1.5fr .6fr .6fr 1fr;align-items:center} .bd-head{font-size:11px;color:var(--muted);padding:0 4px 8px;border-bottom:1px solid var(--border)} .bd-row{font-size:13px;padding:9px 4px;border-bottom:1px solid var(--alt)} /* Report grid */ .metrics-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(165px,1fr))} .metrics-grid .m{padding:12px 14px;border-bottom:1px solid var(--border);border-right:1px solid var(--border)} .metrics-grid .m .lab{color:var(--muted);font-size:11.5px;margin-bottom:4px} .metrics-grid .m .val{font-weight:700;font-size:16px} /* Inputs */ .field{display:block;margin-top:12px} .field span{display:block;color:var(--muted);font-size:12px;margin-bottom:5px} input,select,textarea{font-family:inherit} .inp{width:100%;background:var(--surface);color:var(--text);border:1px solid var(--border);border-radius:8px;padding:9px 11px;font-size:14px} /* Modal */ .modal-bg{position:fixed;inset:0;background:rgba(27,42,74,.35);display:none;place-items:center;padding:16px;z-index:50} .modal-bg.open{display:grid} .modal{background:var(--surface);border-radius:16px;padding:22px;width:100%;max-width:520px;max-height:90vh;overflow:auto} .modal h3{margin:0 0 16px;font-size:17px} .row-end{display:flex;justify-content:flex-end;gap:10px;margin-top:16px} .empty{display:grid;place-items:center;min-height:90px;color:var(--muted);font-size:13px;text-align:center;padding:16px} .chart-box{height:230px;position:relative} iframe.tv{width:100%;height:460px;border:0;display:block;border-radius:10px} @media(max-width:820px){.grid2{grid-template-columns:1fr}}
In the last decade, the field of biotechnology has been transformed by the discovery of CRISPR-Cas9, a powerful tool that allows scientists to edit DNA with surgical precision. Often described as "genetic scissors," CRISPR enables researchers to modify, delete, or replace specific sequences of the genetic code in living organisms. The implications for medicine are staggering; for the first time in history, we possess the capability to potentially cure hereditary diseases such as sickle cell anemia or cystic fibrosis by correcting the underlying mutations at their source. Clinical trials are already showing remarkable success, offering hope to millions of patients who previously had no viable treatment options.
[Image of CRISPR-Cas9 gene editing mechanism]However, the ability to rewrite the blueprint of life brings forth profound ethical dilemmas that society is not yet fully prepared to address. While using gene editing to treat terminal illnesses is widely supported, the prospect of "germline editing"—modifying embryos so that changes are passed down to future generations—remains highly controversial. This raises the specter of "designer babies," where parents could theoretically select traits like intelligence, height, or physical appearance. Such a scenario could exacerbate social inequalities, creating a genetic divide between those who can afford enhancements and those who cannot. Furthermore, the long-term biological consequences of altering the human gene pool are unknown and potentially irreversible.
Beyond human health, CRISPR is revolutionizing agriculture and environmental conservation. Scientists are developing crops that are resistant to drought and pests, which is essential for food security in a changing climate. There are even discussions about using "gene drives" to eradicate malaria by making mosquitoes unable to carry the parasite. Yet, altering entire ecosystems carries the risk of unintended ecological collapse. As we stand on the threshold of a new biological era, the challenge will be to establish international regulations that foster scientific breakthroughs while preventing the misuse of this god-like power. The dialogue between scientists, ethicists, and the public must remain transparent to ensure that genetic engineering serves the common good.
Nell'ultimo decennio, la biotecnologia è stata trasformata dalla scoperta di CRISPR-Cas9, uno strumento che permette di modificare il DNA con precisione chirurgica. Queste "forbici genetiche" offrono la possibilità di curare malattie ereditarie correggendo le mutazioni alla fonte. Tuttavia, la capacità di riscrivere il codice della vita solleva dilemmi etici, specialmente riguardo alla modifica degli embrioni (germline editing) e al rischio di creare "bambini su misura". Questo potrebbe aumentare le disuguaglianze sociali e avere conseguenze biologiche irreversibili. CRISPR viene usato anche in agricoltura per creare colture resistenti alla siccità, ma modificare gli ecosistemi comporta rischi ecologici. La sfida è creare regolamentazioni internazionali che bilancino progresso e sicurezza.
| Scissors: Forbici | Staggering: Sbalorditivo / Impressionante |
| Hereditary: Ereditario | Blueprint: Progetto / Modello |
| Germline: Linea germinale (ereditaria) | Specter: Spettro / Ombra |
| Traits: Tratti / Caratteristiche | Exacerbate: Esacerbare / Peggiorare |
| Breakthroughs: Scoperte / Passi avanti | Misuse: Uso improprio / Abuso |
| Precision: The quality of being exact and accurate. |
| Mutation: A change in the genetic structure of an organism. |
| Viable: Capable of working successfully; feasible. |
| Profound: Very great or intense; having deep meaning. |
| Scenario: A written outline of a movie or a possible sequence of events. |
| Enhancement: An improvement or increase in the quality or value of something. |
| Irreversible: Not able to be undone or altered. |
| Resistant: Offering opposition to something; not affected by something. |
| Threshold: The level or point at which something starts to happen. |
| Transparent: Easy to perceive or detect; honest and open. |
Relative clauses give more information about a noun. Who is for people, which for things, and that for both.
✔ Patients who had no treatment options. (Who refers to patients).
✔ A tool which allows scientists to edit DNA. (Which refers to the tool).
✔ Changes that are passed down. (That refers to changes).
What is "germline editing"?
Il percorso Studentebox nasce per aiutarti a migliorare la lingua spagnola attraverso una lettura guidata, naturale e progressiva. Ogni articolo è scritto in lingua reale, con audio, traduzione, vocabolario, regole grammaticali e quiz di verifica.
📚 Con l'abbonamento annuale ottieni accesso a:
💳 Costo abbonamento:
✔️ 100€ per una singola lingua (Spagnolo, Inglese, Francese o Tedesco)
Completa il pagamento online in modo sicuro.
L’accesso viene attivato entro poche ore.
Pagamento sicuro • Carta • PayPal • Bonifico